HealthTech World Cancer Day 2019 - Portugal
A pan-European HealthTech event
“Smarter Technologies to beat cancer”
The HealthTech World Cancer day (HWCD) is a pan-European event that will be held simultaneously in 10+ European cities on the 1st February 2019. The HWCD aims at raising public awareness about the great innovations of emerging medical technologies in oncology: nanomedicine, photonics, robotics, smart devices, biomaterials, etc.
The Portuguese
event will take place at the auditorium of the International Iberian
Nanotechnology Laboratory (INL) in Braga, on February 1st. Organized by INL under the aegis of ETPN, the press conference will be open to
journalists and general public (registration is mandatory).
Language: Portuguese
AGENDA
9h00-9h30 – Registration and Coffee
9h30-11h00 - Conference
Moderating the session Paulo Freitas, Deputy Director General, INL
9h30-9h40 – Lars Montelius, Director General of INL, ETPN representative - Welcome: Smarter technologies to beat cancer - Sessão de abertura: Tecnologias intelligentes para combater o cancro .
9h40-10h00 – Cristiana Fonseca, Portuguese Cancer Patients Association, Union for International Cancer Control – “ I am a patient support association and I will use technology to fight against cancer "Eu Sou uma associação de apoio ao doente e eu vou usar a tecnologia para lutar contra o cancro”.
10h00-10h20 – Daniela Pereira, NBiON – Magnetoliposomes: a new approach for cancer therapy – Magnetolipossomas: uma nova abordagem para a terapia do cancro.
10h20-10h40 – Jose Luis Costa, Institute for Research and Innovation in Health- i3S – New genomic technologies to better understand and treat cancer patients - Novas tecnologias genómicas para perceber e tratar melhor o doente oncologico
10h40-11h00 – Joaquim Abreu de Sousa, Portuguese Institute of Oncology (IPO) – Cancer in Portugal: present and future – O cancro em Portugal: presente e future.
11h00-11h15 – Final Discussion and Closure; Debate e clausura
People
Lars Montelius - Director General of INL, ETPN representative
Paulo Freitas – Deputy Director General of INL, moderator
Cristiana Fonseca – Coordinator, Health Education Department, Portuguese Cancer Patients Association, Member of the Directive Board of the Union for International Cancer Control
Daniela Pereira – Founder, NBiON
Jose Luis Costa – Principal Researcher, Genetic Dynamics of Cancer Cells, i3S - Ipatimup
Joaquim Abreu de Sousa – Director, Surgical Oncology Service, Portuguese Institute of Oncology - Porto
For more information, please visit www.hwcd.eu